Last reviewed · How we verify

L-theanine

University of British Columbia · FDA-approved active Small molecule Quality 2/100

L-theanine is a Small molecule drug developed by University of British Columbia. It is currently FDA-approved.

At a glance

Generic nameL-theanine
SponsorUniversity of British Columbia
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about L-theanine

What is L-theanine?

L-theanine is a Small molecule drug developed by University of British Columbia.

Who makes L-theanine?

L-theanine is developed and marketed by University of British Columbia (see full University of British Columbia pipeline at /company/university-of-british-columbia).

What development phase is L-theanine in?

L-theanine is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing